Codexis (NASDAQ:CDXS) with $16 Target Got Analyzed By Stephens.

May 17, 2018 - By Elliot Rainer

Codexis, Inc. (NASDAQ:CDXS) Corporate Logo

During Q4 2017 the big money sentiment decreased to 2.17. That’s change of 0.03, from 2017Q3’s 2.2. 3 investors sold all, 15 reduced holdings as Codexis, Inc. ratio dived. 27 increased holdings while 12 funds amassed holdings. Funds hold 28.02 million shares thus 9.42% more from 2017Q3’s 25.60 million shares.

Virtu Ltd Liability holds 0.01% in Codexis, Inc. (NASDAQ:CDXS) or 24,209 shs. Bancorp Of Montreal Can owns 1,324 shs. Telemark Asset Lc stated it has 3.25 million shs. Metropolitan Life Insur Ny holds 0% of its capital in Codexis, Inc. (NASDAQ:CDXS) for 10,879 shs. Morgan Stanley reported 91,201 shs. State Street has invested 0% in Codexis, Inc. (NASDAQ:CDXS). Northern Trust Corporation holds 0% of its capital in Codexis, Inc. (NASDAQ:CDXS) for 429,439 shs. State Board Of Administration Of Florida Retirement Sys has invested 0% in Codexis, Inc. (NASDAQ:CDXS). Vantage Inv Lc reported 3,252 shs. Prelude Capital Ltd Liability Company has 0.03% invested in Codexis, Inc. (NASDAQ:CDXS) for 48,891 shs. United Kingdom-based Legal And General Grp Incorporated Public Limited Company has invested 0% in Codexis, Inc. (NASDAQ:CDXS). Perkins Cap Mngmt Incorporated reported 30,000 shs stake. Rhumbline Advisers owns 35,893 shs. Citigroup holds 0% or 4,197 shs in its capital. Blackrock holds 2.67M shs.

Codexis, Inc. registered $1.45 million net activity with 0 insider buys and 6 sales since March 21, 2018. On Monday, March 26 WOLF DENNIS P sold $464,384 worth of Codexis, Inc. (NASDAQ:CDXS). On Wednesday, March 28 a trade for 25,000 shs valued at $276,318 was made by BARUCH THOMAS R. Another trade for 22,465 shs valued at $259,828 was sold by NICOLS JOHN J. On Tuesday, April 3 Smith David V had sold 6,000 shs worth $62,213. KELLEY BERNARD J sold $124,683 worth of stock.

What Price Target Has Stephens Given Codexis (NASDAQ:CDXS)

upside potential of 14.70 % on Codexis (NASDAQ:CDXS) indicates $16 target price given by Equity analysts at Stephens. Also on 16 May coverage has initiated by broker on the $742.70M market cap company.

Codexis, Inc. (NASDAQ:CDXS) Ratings Coverage

Total analysts of 2 have positions in Codexis (NASDAQ:CDXS) as follows: 2 rated it a “Buy”, 0 with “Sell” and 0 with “Hold”. The positive are 100%. The firm has $1600 highest while $11.5 is the lowest target price. The average target $13.75 is -1.43% below the last ($13.95) price. Since March 12, 2018 according to StockzIntelligence Inc Codexis has 2 analyst reports. On Wednesday, May 16 the company was initiated by Stephens. On Monday, March 12 the rating was maintained by H.C. Wainwright with “Buy”.

Ticker’s shares touched $13.95 during the last trading session after 5.28% change.Codexis, Inc. has 602,084 shares volume, 41.77% up from normal. CDXS is uptrending and has moved 125.77% since May 17, 2017. The stock outperformed the S&P 500 by 114.22%.

Codexis, Inc. (NASDAQ:CDXS) is anticipated to report earnings on August, 8., RTT reports. Analysts forecast 76.92 % diference or $-0.03 from the $-0.13 EPS from 2017. Last quarter $-0.10 EPS was reported. Analysts predicts -70.00 % EPS growth this quarter.

Codexis, Inc. discovers, develops, and sells protein catalysts.The firm is worth $742.70 million. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable clients to perform chemistry screening.Currently it has negative earnings. The firm also provides protein catalyst screening and protein engineering services.

For more Codexis, Inc. (NASDAQ:CDXS) news posted briefly go to: Globenewswire.com, Seekingalpha.com, Seekingalpha.com, Globenewswire.com or Nasdaq.com. The titles are as follows: “Codexis to Hold First Quarter 2018 Conference Call on May 10” posted on May 03, 2018, “Premarket analyst action – healthcare” on May 16, 2018, “Codexis’ (CDXS) CEO John Nicols on Q1 2018 Results – Earnings Call Transcript” with a publish date: May 11, 2018, “Codexis Reports First Quarter 2018 Financial Results” and the last “3 High-Growth Stocks That Are Just Getting Started” with publication date: May 12, 2018.

Codexis, Inc. (NASDAQ:CDXS) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: